Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07263100Completed
Randomised trial in Hypertrophic Scar (HS) and keloid (3 arms), sponsored by Somdech Phra Nangchao Sirikit Hospital. Primary endpoint: Vancouver Scar Scale at 5 months. Started May 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07263100.